Company Filing History:
Years Active: 1997-1999
Title: The Innovative Contributions of Kenneth J Wieder: Pioneering Research in HIV
Introduction: Kenneth J Wieder, an esteemed inventor based in Dedham, MA, has made significant strides in the field of biomedical research, particularly concerning HIV infection. With a total of two patents to his name, Wieder’s work has the potential to pave the way for new therapeutic approaches in the fight against HIV.
Latest Patents: Wieder's most notable patents are centered around the invention of a gene encoding a mutant L3T4 protein. This innovative protein, when expressed on the surface of a cell, can facilitate the infection of that cell by the human immunodeficiency virus. The patent details a DNA sequence that incorporates at least one amino acid residue substitution or deletion, enhancing the homology between the gp120 binding epitope of the mutant L3T4 protein and its CD4 protein counterpart. Additionally, the patent encompasses the creation of a murine cell line transfected with this DNA sequence, as well as a transgenic mouse model susceptible to HIV infection, which can be invaluable for research and therapeutic testing.
Career Highlights: Kenneth J Wieder has contributed to prestigious institutions such as Beth Israel Hospital and Beth Israel Hospital Association, where he applied his expertise to advance medical research and innovation. His experience in these organizations reflects a dedicated commitment to exploring novel solutions for pressing medical challenges.
Collaborations: During his career, Wieder has collaborated with notable individuals such as Terry Barton Strom. Their joint efforts have likely fostered groundbreaking discoveries that have furthered the understanding of HIV and its mechanisms.
Conclusion: Kenneth J Wieder represents the spirit of innovation and determination in the scientific community. His patents and collaborative work exemplify how dedicated inventors contribute to our understanding of complex diseases like HIV. As research continues, Wieder’s contributions will undoubtedly play a crucial role in developing future therapeutic interventions.